Department of Biochemistry

January 28, 2016

Nobel laureate’s lecture highlights impact of science

“Stay with science,” Nobel laureate Peter Agre, M.D., advised dozens of medical and graduate students who attended his lecture at Vanderbilt University Medical Center last week. “It will take you to fascinating places.”

By VUMC News and Communications
model of DNA double helix
January 22, 2016

Faulty building blocks in DNA

An enzyme that builds DNA is able to insert the wrong building blocks, which could generate mutations.

By Bill Snyder
January 14, 2016

‘Science diplomacy’ focus of Nobel laureate Agre’s Discovery Lecture

Peter Agre, M.D., a Nobel laureate who advocates the use of medical science to advance international diplomacy, will deliver the next Flexner Discovery Lecture at 4 p.m. Thursday, Jan. 21, in room 208 Light Hall.

By Bill Snyder
January 8, 2016

Copying chromosome caps

Telomeres – the caps on the end of chromosomes – are a source of stress for a particular protein involved in copying DNA, a new study reports.

By Leigh MacMillan
DNA sequence visualization
November 12, 2015

Study helps clarify components of DNA ‘copy machine’

Vanderbilt investigators have generated a “parts list” for the molecular machinery that duplicates DNA each time a cell divides. The research has implications for cancer therapies that target components of this machinery.

By Leigh MacMillan
October 22, 2015

Chazin honored with international biophysics award

Walter Chazin, Ph.D., director of the Vanderbilt Center for Structural Biology, is a recipient of a 2016 Fellow of the Biophysical Society award.

By Bill Snyder
October 8, 2015

Komen, VICC partnership bolsters breast cancer research

For more than twenty years, Vanderbilt-Ingram Cancer Center’s (VICC) primary source of outside funding has been provided by the National Institutes of Health. But in breast cancer, Susan G. Komen, a nonprofit dedicated to breast cancer research and community services, has been a significant sponsor of research and patient care support.
By VUMC News and Communications
October 7, 2015

Rational design of novel antifungals

Structural and molecular details of an anti-fungal target's interaction with inhibitors suggest ways to design better treatments for fungal infections.
By VUMC News and Communications
October 2, 2015

The yin and yang of COX-2

New findings add to the understanding of how the enzyme COX-2 works, which is critical to the development of COX-2-targeted anti-inflammatory drugs.
By Sanjay Mishra
October 1, 2015

VICC investigators land Komen breast cancer grants

Two Vanderbilt-Ingram Cancer Center (VICC) investigators — Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of VICC, and Valerie Jansen, M.D., Ph.D., medical oncology fellow — have received new cancer research grants awarded by Susan G. Komen, the world’s largest nonprofit funder of breast cancer research.
By VUMC News and Communications
September 17, 2015

Strong scores put VICC among top NCI centers

Vanderbilt-Ingram Cancer Center (VICC) has been recognized for the impact of its research programs and excellence in patient care by a panel of National Cancer Institute (NCI) reviewers, receiving an overall “exceptional” score as part of the renewal of the Cancer Center Support Grant (CCSG).
By VUMC News and Communications
August 26, 2015

Framework for studying cell responses

Vanderbilt investigators have developed a framework for studying cellular responses that could be used to identify the agents driving a range of biological processes in health and disease.
By Leigh MacMillan
August 25, 2015

How the cell makes morphine

Vanderbilt investigators have discovered how mammals, including humans, produce the painkiller morphine.
By Sanjay Mishra
1 … 9 10 11 12 13 … 16